Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron + dexamethasone + droperidol versus palonosetron + dexamethasone for prevention of postoperative nausea and vomiting in gynecologic laparoscopy
ChiCTR2200062263Phase 4Not yet recruiting
- Sponsor
- Jinan University
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of palonosetron, dexamethasone and droperidol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Jinan University. Primary endpoints: Incidence of postoperative nausea and vomiting within 6 hours after operation and Incidence of postoperative nausea and vomiting within 6 to 24 hours after operation. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
palonosetrondexamethasonedroperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2200062263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062263.